Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stepping into nursing research: an introduction for gastroenterology and hepatology nurses.
Munnelly S, Radford SJ, Datt P, Donnelly L, Fraser A, Gil-Zaragozano E, Jack K, Watson H, Iqbal TH, Sebastian S, Kemp K. Munnelly S, et al. Among authors: iqbal th. Frontline Gastroenterol. 2023 Sep 14;15(2):137-143. doi: 10.1136/flgastro-2023-102493. eCollection 2024 Mar. Frontline Gastroenterol. 2023. PMID: 38486666 Free article. Review.
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Mullish BH, Merrick B, Quraishi MN, Bak A, Green CA, Moore DJ, Porter RJ, Elumogo NT, Segal JP, Sharma N, Marsh B, Kontkowski G, Manzoor SE, Hart AL, Settle C, Keller JJ, Hawkey P, Iqbal TH, Goldenberg SD, Williams HRT. Mullish BH, et al. Among authors: iqbal th. J Hosp Infect. 2024 Apr 11:S0195-6701(24)00080-X. doi: 10.1016/j.jhin.2024.03.001. Online ahead of print. J Hosp Infect. 2024. PMID: 38609760
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Mullish BH, Merrick B, Quraishi MN, Bak A, Green CA, Moore DJ, Porter RJ, Elumogo NT, Segal JP, Sharma N, Marsh B, Kontkowski G, Manzoor SE, Hart AL, Settle C, Keller JJ, Hawkey P, Iqbal TH, Goldenberg SD, Williams HRT. Mullish BH, et al. Among authors: iqbal th. Gut. 2024 Apr 12:gutjnl-2023-331550. doi: 10.1136/gutjnl-2023-331550. Online ahead of print. Gut. 2024. PMID: 38609165
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease.
Saviano A, Schettino A, Iaccarino N, Mansour AA, Begum J, Marigliano N, Raucci F, Romano F, Riccardi G, Mitidieri E, d'Emmanuele di Villa Bianca R, Bello I, Panza E, Smimmo M, Vellecco V, Rimmer P, Cheesbrough J, Zhi Z, Iqbal TH, Pieretti S, D'Amore VM, Marinelli L, La Pietra V, Sorrentino R, Costa L, Caso F, Scarpa R, Cirino G, Randazzo A, Bucci M, McGettrick HM, Iqbal AJ, Maione F. Saviano A, et al. Among authors: iqbal th. J Autoimmun. 2024 Apr;144:103181. doi: 10.1016/j.jaut.2024.103181. Epub 2024 Mar 23. J Autoimmun. 2024. PMID: 38522129
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.
Bai BYH, Reppell M, Smaoui N, Waring JF, Pivorunas V, Guay H, Lin S, Chanchlani N, Bewshea C, Goodhand JR, Kennedy NA, Ahmad T, Anderson CA; UK Inflammatory Bowel Disease Pharmacogenetics Study Group. Bai BYH, et al. J Crohns Colitis. 2024 Mar 1;18(3):431-445. doi: 10.1093/ecco-jcc/jjad166. J Crohns Colitis. 2024. PMID: 37776235 Free PMC article.
82 results